skip to main content

Combo Device Strategies: Pathways to Market

When
September 18, 2025
3:30 - 8:00 PM

Where
M2D2 - UMass Lowell, 110 Canal St, 3rd Floor
Lowell, MA 01852

Join MDG Boston and M2D2 on September 18th from 4:00 - 8:00 PM for Combo Drug & Device Strategies: Pathways to Market, a dynamic innovation event bringing together leaders from across the healthcare and life sciences ecosystem to explore the unique challenges and opportunities in developing and commercializing combination drug-device products.

Deirdre Sanders, Principal at Hamilton Brook Smith Reynolds will join a panel discussion with strategic industry experts and regulatory leaders to share insights into the evolving pathways to market for combination products, including regulatory strategy, clinical validation, reimbursement considerations, and partnering opportunities.

Attendees will have the opportunity to hear the latest and greatest from innovators developing cutting-edge combo products - they will pitch their technologies and share how they are navigating the investment landscape and regulatory and other hurdles as they advance their technologies toward commercialization.

This event is meant to foster meaningful dialogue, partnership opportunities, and practical takeaways for anyone involved in the development and deployment of combination devices.

AGENDA

  • 3:30: Check in, Poster sessions & Networking
  • 5:00: Welcome / Opening remarks / Keynote
  • 5:45: Panel Discussion followed by Q&A
  • 6:30: Pitch presentations
  • 7:15: Posters sessions & Networking
  • 8:00: Program close

Who Should Attend:

  • Medtech and Biopharma Innovators developing or exploring combination products
  • Business Development & Strategy Leaders seeking innovation & partnership opportunities
  • Investors & Venture Partners interested in early-stage drug-device technologies
  • Academic and Clinical Researchers working at the intersection of drug delivery and device engineering
  • Healthcare and Medtech Industry Partners supporting product development and commercialization
  • Innovation & Entrepreneurship business professors & student
  • Entrepreneurial engineering students
  • Healthcare innovation enthusiasts!

Panel Presenters:

  • Ibraheem Badejo, PhD, MLS - Senior R&D Director, External Innovation, Johnson & Johnson
  • Barry Sands - President & Founder, RQMIS
  • Deirdre Sanders - Principal, Hamilton Brook Smith Reynolds
  • Bill Geary - Intellectual Property Lawyer, Mintz
  • Kristofer Munroe - Director, Compliance, Reimbursement, Health Economics, Market Access, Pria
  • Ray Dunn, MD - Chairman of Plastic Surgery, UMass Chan Medical School
  • Bryan Nolan - Founder & CEO, myBiometry